Levofloxacin Kabi Use In Pregnancy & Lactation

Pregnancy: There are limited amount of data from the use of levofloxacin in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. However in the absence of human data and due to that experimental data suggest a risk of damage by fluoroquinolones to the weight-bearing cartilage of the growing organism, Levofloxacin Kabi solution for infusion must not be used in pregnant women (see Contraindications).
Breast-feeding: Levofloxacin Kabi is contraindicated in breast-feeding women. There is insufficient information on the excretion of levofloxacin in human milk; however other fluoroquinolones are excreted in breast milk. In the absence of human data and due to that experimental data suggest a risk of damage by fluoroquinolones to the weight-bearing cartilage of the growing organism, Levofloxacin Kabi solution for infusion must not be used in breast-feeding women (see Contraindications).
Fertility: Levofloxacin caused no impairment of fertility or reproductive performance in rats.